CFGS
OPRX icon

Concourse Financial Group Securities’s OptimizeRx OPRX Stock Holding History

Concourse Financial Group Securities’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-493
Closed -$9.74K – 2216
2022
Q2 		$14K Sell
493
-53
-10% -$1.57K ﹤0.01% 1564
2022
Q1 		$21K Buy
546
+269
+97% +$11.9K ﹤0.01% 1471
2021
Q4 		$17K Buy
277
+36
+15% +$2.73K ﹤0.01% 1704
2021
Q3 		$21K Buy
241
+39
+19% +$2.45K ﹤0.01% 1648
2021
Q2 		$13K Buy
+202
New +$10.3K ﹤0.01% 1786

Other funds holding OPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Concourse Financial Group Securities's OPRX Position: Q3 2022 in Review

Concourse Financial Group Securities sold out of OptimizeRx (OPRX) in Q3 2022, closing a stake of 493 shares — an estimated $9.74K sold.

Concourse Financial Group Securities first reported a position in OPRX in Q2 2021 and held it in 5 quarters. The position peaked at $21K in Q1 2022. 128 funds tracked by Wall St. Rank hold OPRX as of Q3 2022.

  • Concourse Financial Group Securities reported no remaining OptimizeRx position as of Q3 2022 after selling out during the quarter.
  • Concourse Financial Group Securities sold 493 OptimizeRx shares in Q3 2022, an estimated $9.74K.
  • Concourse Financial Group Securities first reported a position in OptimizeRx in Q2 2021 and held it in 5 quarters.
  • Concourse Financial Group Securities's OptimizeRx position peaked at $21K in Q1 2022.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2022.

Based on Concourse Financial Group Securities's 13F filing for Q3 2022, filed 15 Nov 2022.